Johnson & Johnson, Eli Lilly, Sanofi and Bristol Myers Squibb are suing the federal government over the future of their 340B drug rebate plans. The lawsuits reflect rising tensions among ...

The 340B requirement has long been a bone of contention ... Last year, for example, a federal appeals court sided with Sanofi, AstraZeneca, and Novo Nordisk in a dispute claiming that recipients ...

The largest life sciences association in the state recognized those driving discovery during its 32nd annual dinner meeting ...

Recently, Sanofi-Aventis US LLC filed a lawsuit against the Department of Health and Human Services (HHS) and the Health Resources and Services Administration (HRSA) over changes to the 340B program.

Recently, Sanofi-Aventis US LLC filed a lawsuit against the Department of Health and Human Services (HHS) and the Health Resources… Subscribe To Our Daily News Sign up here to get the latest news and ...

B Health and two safety-net hospitals want to help the government prove that drugmakers are required to give upfront discounts on 340B drugs.

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far so we are determined to hang on ...

To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Sanofi and Johnson & Johnson are ending a Phase 3 study of an experimental E. coli vaccine after it ...

Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a U.S. drug ingredients plant tied to its longstanding subsidiary Genzyme.